Long-term neuroprotection achieved with latency-associated promoter-driven herpes simplex virus gene transfer to the peripheral nervous system (Q45456081)

From Wikidata

Jump to navigation Jump to search

scientific article published in August 2005

Language	Label	Description	Also known as
English	Long-term neuroprotection achieved with latency-associated promoter-driven herpes simplex virus gene transfer to the peripheral nervous system	scientific article published in August 2005

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Long-term neuroprotection achieved with latency-associated promoter-driven herpes simplex virus gene transfer to the peripheral nervous system (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

author name string

Munmun Chattopadhyay

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Darren Wolfe

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Marina Mata

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Shaohua Huang

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Joseph C Glorioso

5

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

David J Fink

6

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

publication date

1 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Molecular Therapy

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

307-313

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Development and application of herpes simplex virus vectors for human gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Development and optimization of herpes simplex virus vectors for multiple long-term gene delivery to the peripheral nervous system

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Herpes vector-mediated gene transfer in treatment of diseases of the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Protective effect of herpes simplex virus-mediated neurotrophin gene transfer in cisplatin neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Protective effect of HSV-mediated gene transfer of nerve growth factor in pyridoxine neuropathy demonstrates functional activity of trkA receptors in large sensory neurons of adult animals

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Bcl-2 and GDNF delivered by HSV-mediated gene transfer after spinal root avulsion provide a synergistic effect

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Herpes simplex-mediated gene transfer of nerve growth factor protects against peripheral neuropathy in streptozotocin-induced diabetes in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Transgene-mediated enkephalin release enhances the effect of morphine and evades tolerance to produce a sustained antiallodynic effect in neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Herpes vector-mediated expression of proenkephalin reduces bone cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Neurotrophin-3 administration attenuates deficits of pyridoxine-induced large-fiber sensory neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

In vivo gene therapy for pyridoxine-induced neuropathy by herpes simplex virus-mediated gene transfer of neurotrophin-3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Nerve growth factor prevents experimental cisplatin neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Nerve growth factor administration protects against experimental diabetic sensory neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Viral and non-viral gene therapy partially prevents experimental cisplatin-induced neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Intraputamenal infusion of GDNF in aged rhesus monkeys: Distribution and dopaminergic effects

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Continuous delivery of neurotrophin 3 by gene therapy has a neuroprotective effect in experimental models of diabetic and acrylamide neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Comparative analysis of genomic HSV vectors for gene delivery to motor neurons following peripheral inoculation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Herpes simplex virus type 1 ICP0 protein does not accumulate in the nucleus of primary neurons in culture

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Evidence for a bidirectional element located downstream from the herpes simplex virus type 1 latency-associated promoter that increases its activity during latency

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Enhancer and long-term expression functions of herpes simplex virus type 1 latency-associated promoter are both located in the same region

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Viral shedding and biodistribution of G207, a multimutated, conditionally replicating herpes simplex virus type 1, after intracerebral inoculation in aotus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Replication-defective herpes simplex virus vectors for gene transfer in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Safety and biodistribution studies of an HSV multigene vector following intracranial delivery to non-human primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

The latency-associated promoter of herpes simplex virus type 1 requires a region downstream of the transcription start site for long-term expression during latency

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.04.009

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.YMTHE.2005.04.009

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45456081&oldid=2076964299"